Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Micro-costing for national-scale azithromycin mass drug administration to improve child survival in Niger.

PLOS global public health·2026
Same author

Predictors of home- vs. facility-based delivery among women living in rural Niger: a cross-sectional survey within the AVENIR cluster-randomised trial.

Journal of global health·2026
Same author

Zoonotic and Anthroponotic Plasmodium spp. Circulation between Wild Primates and Indigenous Community, Peruvian Amazon, 2007-2020.

Emerging infectious diseases·2026
Same author

Comparing the Generalizability of Multiregional versus Locally Trained Deep Learning Models for Trachoma Detection.

Ophthalmology science·2026
Same author

Mass azithromycin distribution and antibiotic resistance in the gut and nasopharynx: a cluster-randomized trial.

Nature medicine·2026
Same author

Azithromycin mass drug administration to reduce child mortality in Niger (AVENIR II): a master protocol for a cluster-randomized adaptive platform trial to evaluate community-based health interventions.

Trials·2026

相关实验视频

Updated: Jun 26, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.3K

使用血清学来表征气管瘤消除的特征

Everlyn Kamau1, Pearl Anne Ante-Testard1, Sarah Gwyn2

  • 1F.I. Proctor Foundation, University of California San Francisco, USA.

medRxiv : the preprint server for health sciences
|October 14, 2024
PubMed
概括

这项研究引入了一种新的方法,用于评估使用儿童抗体测量对Chlamydia trachomatis的传播. 它有助于确定气管瘤消除计划是否需要继续或可以缩减.

更多相关视频

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.3K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.1K

相关实验视频

Last Updated: Jun 26, 2026

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
10:05

Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut

Published on: May 24, 2011

16.3K
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.3K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.1K

科学领域:

  • 公共卫生 公共卫生
  • 传染病流行病学 传染病流行病学
  • 免疫学 免疫学 免疫学

背景情况:

  • 到2030年,消除气管瘤是全球卫生重点之一.
  • 针对儿童的血清IgG抗体测量正在进行监测.
  • 缺乏血清学应用指南是消除疾病的一个挑战.

研究的目的:

  • 开发一种可通用的方法,用于使用血清学在瘤监测.
  • 为了估计人口水平的血清转化率 (SCR) 在不同的特有性水平.
  • 提出SCR的门,以告知计划决策.

主要方法:

  • 在48次血清调查中对63,911名儿童 (年龄为1至9岁) 的克拉米迪亚形虫Pgp3和CT694IgG测量进行了对照.
  • 分析来自非洲,拉丁美洲和太平洋岛屿的数据.
  • 估计人口水平的血清转化率 (SCR) 沿着一个梯度的气管瘤流行性.

主要成果:

  • 开发了一种新的,可通用的方法来估计C. trachomatis的传播概率.
  • 在不同地理区域和特有性水平上估计了人口水平的SCR.
  • 确定了SCR的潜在门,以指导计划性行动.

结论:

  • 拟议的血清学方法可以为轨道瘤计划的决策提供信息.
  • 这种方法提供了一种评估传播和指导消除干预的方法.
  • 血清学提供了一种有价值的工具,用于监测实现气管瘤消除目标的进展.